Wahab, Noorul
Toss, Michael
Miligy, Islam M.
Jahanifar, Mostafa
Atallah, Nehal M.
Lu, Wenqi
Graham, Simon
Bilal, Mohsin
Bhalerao, Abhir
Lashen, Ayat G. http://orcid.org/0000-0001-9494-7382
Makhlouf, Shorouk http://orcid.org/0000-0003-3889-9659
Ibrahim, Asmaa Y.
Snead, David
Minhas, Fayyaz http://orcid.org/0000-0001-9129-1189
Raza, Shan E. Ahmed http://orcid.org/0000-0002-1097-1738
Rakha, Emad
Rajpoot, Nasir http://orcid.org/0000-0002-4706-1308
Funding for this research was provided by:
Innovate UK (104689, 104689, 104689, 104689, 104689, 104689, 104689, 104689, 104689, 104689, 104689, 104689, 104689, 104689, 104689, 104689, 104689)
Article History
Received: 19 May 2023
Accepted: 24 October 2023
First Online: 15 November 2023
Competing interests
: S.G., D.S. and N.R. are co-founders of Histofy Ltd. F.M., S.G., D.S. and N.R. are shareholders in Histofy Ltd. F.M. and N.R. report research funding from GlaxoSmithKline. N.R. is also in receipt of research funding from AstraZeneca. The other authors declare no competing interests.